Sort
23,748 grants matching “melanoma”
TOTAL SYNTHESES OF INDOLE ALKALOIDS
$346,891University Of Vermont &St Agric College · R01 · FY2001 · CA
Cancer and Leukemia Group B: RPCI/SUNYAB
$346,791Roswell Park Cancer Institute Corp · U10 · FY2003 · CA
Investigating p16 Loss in Pro-tumorigenic Metabolism
$346,730Katherine Marie Aird · University Of Pittsburgh At Pittsburgh · R37 · FY2023 · CA
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
$346,719Joanna Phillips · University Of California, San Francisco · R01 · FY2015 · NS
Heparan sulfate proteoglycans as critical regulators of brain cancer malignancy
$346,719Joanna Phillips · University Of California, San Francisco · R01 · FY2016 · NS
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
$346,690Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2020 · CA
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
$346,690Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2017 · CA
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
$346,690Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2021 · CA
Mechanism-based targeting of unique survival signaling in residual tumors
$346,690Kris C. Wood · Duke University · R01 · FY2023 · CA
Optical Mapping of Nonmelanoma Skin Cancers
$346,675Massachusetts General Hospital · R01 · FY2005 · EB
Penn Small Animal Imaging Resource (Penn-SAIR)
$346,675Jerry D Glickson · University Of Pennsylvania · U24 · FY2011 · CA
Endothelial Transdifferentiation of Invasive Tumor Cells
$346,658Mary J.c. Hendrix · Lurie Children'S Hospital Of Chicago · R37 · FY2006 · CA
Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy
$346,635Stanley R Riddell · Fred Hutchinson Cancer Center · P50 · FY2023 · CA
Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy
$346,635Stanley R Riddell · Fred Hutchinson Cancer Center · P50 · FY2022 · CA
Project 2: Targeting Neoantigens for Lung Cancer Immunotherapy
$346,634Stanley R Riddell · Fred Hutchinson Cancer Research Center · P50 · FY2019 · CA
Phosphorylatable Monoclonal Antibodies for Tumor Therapy
$346,630Pbl Biomedical Laboratories · R44 · FY2003 · CA
Project 1: Personalized Adjuvant Immunotherapy for High-risk Colorectal Cancer.
$346,624Patrick Hwu · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Rational Design of HMW-MAA Peptide Mimics
$346,608Roswell Park Cancer Institute Corp · R01 · FY2005 · CA
Cohort Study of Genetic Susceptibility to Cutaneous Malignant Melanoma
$346,579Jiali Han · Brigham And Women'S Hospital · R01 · FY2009 · CA
Defining how obesity shapes immunity and the success of cancer immunotherapy
$346,556Ryan M Teague · Saint Louis University · R01 · FY2019 · CA
Defining how obesity shapes immunity and the success of cancer immunotherapy
$346,556Ryan M Teague · Saint Louis University · R01 · FY2021 · CA
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
$346,556Guangyong Peng · Saint Louis University · R01 · FY2020 · CA
Defining how obesity shapes immunity and the success of cancer immunotherapy
$346,556Ryan M Teague · Saint Louis University · R01 · FY2020 · CA
Targeting Lymphatic Vessels for Ligand Directed Imaging
$346,556Renata Pasqualini · University Of New Mexico Health Scis Ctr · R01 · FY2017 · CA
The B7x pathway in the tumor microenvironment
$346,525Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2014 · CA